Full Data on Cayuga’s Novel Synthetic Compound in Stopping Life-Threatening Hemorrhage Shows Promise
PolyP-SNP Complex Has Potential to Restore Blood Clotting Under Most Dangerous Conditions of Traumatic Injury NEW YORK, NY, UNITED STATES, November 5, 2025 /EINPresswire.com/ -- Cayuga Biotech, Inc., a company developing novel therapeutics to …